Therapeutic effects of Serelaxin in acute heart failure
Over the past few decades, research on the peptide hormone, relaxin, has significantly improved our understanding of its biological actions under physiological and diseased conditions. This has facilitated the conducting of clinical trials to explore the use of serelaxin (human recombinant relaxin)....
Main Authors: | Du, X, Hewitson, T, Nguyen, M, Samuel, C |
---|---|
Format: | Journal article |
Published: |
Japanese Circulation Society
2014
|
Similar Items
-
CLINICAL CASE OF USAGE OF SERELAXIN IN THE PATIENT WITH ACUTE DECOMPENSATED HEART FAILURE
by: I. V. Zhirov, et al.
Published: (2016-04-01) -
AN EXPERIENCE OF SERELAXINE USE FOR ACUTE HEART FAILURE IN PATIENTS WITH ONCOHEMATOLOGICAL DISEASES
by: L. A. Shpagina, et al.
Published: (2015-06-01) -
Organoprotective effects of serelaxin in patients with severe decompensated heart failure
by: Z. D. Kobalava, et al.
Published: (2016-09-01) -
NEW PROSPECTS IN PHARMACOLOGICAL TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE. EXPERIENCE WITH SERELAXIN. A CLINICAL CASE
by: S. D. Mayanskaya
Published: (2017-12-01) -
SERELAXIN IN THE STRATEGY OF MANAGEMENT THE PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE: FROM DECREASING OF SYMPTOMS TO THE IMPROVEMENT OF SURVIVAL
by: I. V. Zhirov, et al.
Published: (2015-09-01)